1. Home
  2. TLYS vs GRDX Comparison

TLYS vs GRDX Comparison

Compare TLYS & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$5.45

Market Cap

43.3M

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

N/A

Current Price

$5.27

Market Cap

39.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TLYS
GRDX
Founded
1982
N/A
Country
United States
United Kingdom
Employees
N/A
2
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3M
39.3M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
TLYS
GRDX
Price
$5.45
$5.27
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
381.4K
155.1K
Earning Date
06-03-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
62.34
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.66
N/A
Revenue Next Year
$1.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$1.87
52 Week High
$5.90
$6.93

Technical Indicators

Market Signals
Indicator
TLYS
GRDX
Relative Strength Index (RSI) 67.86 55.12
Support Level $3.62 $2.16
Resistance Level $5.72 $6.93
Average True Range (ATR) 0.45 0.65
MACD 0.09 -0.09
Stochastic Oscillator 70.83 34.17

Price Performance

Historical Comparison
TLYS
GRDX

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: